Italy · Biotechnology startup
Italy · AAVantgarde Bio
AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
Funding reportedLast round: Series A
Follow AAVantgarde Bio and see its new rounds in your feed.Start following
What company datasets say AAVantgarde Bio raised
Funding, as reported
Reported in all141Min the source's currency
Rounds2
Last roundSeries A
Last round dateJun 2023
Investors listed5
On a portfolio page
Investors who name them
Each firm lists AAVantgarde Bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Italy
Startups like it
Is this your company?
Add your raise, your deck and your story, and put AAVantgarde Bio in front of investors. Or tell us what we have wrong.